中国苏州2026年9月15日 /美通社/ -- 亚盛医药(纳斯达克代码:AAPG;香港联交所代码:6855)今日宣布,与北京大学日前举行血液学科医企科研战略合作签约仪式。本次合作将以血液肿瘤为切入点,重点围绕临床研究平台建设、复合型人才培养、科技成果转化机制等多个维度展开。双方将整合临床资源与创新研发优势,共筑血液肿瘤协同创新体系,加快该领域创新成果的临床转化,为患者带来更多获益。 ...
Source Link中国苏州2026年9月15日 /美通社/ -- 亚盛医药(纳斯达克代码:AAPG;香港联交所代码:6855)今日宣布,与北京大学日前举行血液学科医企科研战略合作签约仪式。本次合作将以血液肿瘤为切入点,重点围绕临床研究平台建设、复合型人才培养、科技成果转化机制等多个维度展开。双方将整合临床资源与创新研发优势,共筑血液肿瘤协同创新体系,加快该领域创新成果的临床转化,为患者带来更多获益。 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.